Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on February 21, 2006
Schizophrenia Bulletin 2006 32(2):246-249; doi:10.1093/schbul/sbj054
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
32/2/246    most recent
sbj054v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kirkpatrick, B.
Right arrow Articles by Fischer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirkpatrick, B.
Right arrow Articles by Fischer, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Subdomains Within the Negative Symptoms of Schizophrenia: Commentary

Brian Kirkpatrick1,2 and Bernard Fischer3
2 Department of Psychiatry and Health Behavior, Medical College of Georgia
3 Department of Psychiatry, University of Maryland

Keywords: blunted affect / poverty of speech / negative symptoms / rating scales / psychometrics

In an accompanying article in this theme issue, Blanchard and Cohen review the evidence on the relationships among negative symptoms and conclude that meaningful subdomains within negative symptoms may exist.1 Specifically, they suggest that blunted affect and poverty of speech may form one such subdomain, and anhedonia, asociality, and avolition may form another. The authors are appropriately cautious in raising this possibility, and they suggest further studies would be needed before it is confirmed.

Should the independence of these 2 factors be confirmed, it would have implications for research on negative symptoms. At the Consensus Development Conference on Negative Symptoms, sponsored by the National Institute of Mental Health and held in Rockville, Maryland, on January 26–27, 2005, one of us (Kirkpatrick) presented a review of the literature on blunted affect. From the starting point of that presentation, a pattern consistent with the existence of separate subdomains similar to those cited by Blanchard and Cohen emerged. We briefly summarize that presentation and discuss some of the issues involved in conducting research on the existence of separate factors within negative symptoms.


   Blunted Affect
Top
 Blunted Affect
Data at the Item...
 Future Research
 Conclusion
 References
 
All of the widely used negative symptom rating and categorization instruments include blunted or restricted affect. Blunted affect can be considered to have 3 components: (1) decrease in facial expression; (2) decrease in expressive gestures and other body language; and (3) decrease in modulation of the volume, pitch, and speed of speaking. Blunted affect should be distinguished from flat affect, which refers to the extreme end of the spectrum of blunting. Items for "decreased spontaneous movements" and/or "poor eye contact" are included in some blunted affect subscales; in factor analyses these correlate with the core features of blunted affected but are not part of the same construct.

Blunted affect can be found in several disorders other than schizophrenia, including Parkinson's disease, depression, autism, vascular dementia, and multiple system atrophy.2–7 In the context of schizophrenia, antipsychotic medications complicate the assessment of blunted affect, as they can induce this symptom8 (although this is much less of a problem with second-generation drugs than with the first generation).


   Data at the Item Level
Top
 Blunted Affect
 Data at the Item...
Future Research
 Conclusion
 References
 
In Table 1, we summarize the studies that provided data at the item level of the relationships within negative symptoms. Only studies with schizophrenia subjects were included. We omitted studies that used scales that included symptoms other than negative symptoms.


View this table:
[in this window]
[in a new window]
  		Table 1. Studies of Blunted Affect and Poverty of Speech

 
Consistent with the review of Blanchard and Cohen,1 these studies suggest that blunted affect and poverty of speech have a particularly strong relationship and may constitute a domain with some independence from other domains within negative symptoms. Four of 5 publications that were based on 1 negative symptom rating scale found blunted affect loading onto the same factor as poverty of speech9–12,not13; each of these studies found more than 1 negative symptom factor. Another study evaluated 2 scales in the same population; for both scales blunted affect and poverty of speech loaded onto the same factor.14 A study based on the Schedule for the Deficit Syndrome (SDS) that did not use factor analysis found that the blunted affect and poverty of speech items had a (Spearman) correlation of r = 0.84, compared with other bivariate item correlations of 0.48 to 0.68.15

Several aspects of these studies support the generalizability of the finding of a particularly strong relationship between blunted affect and poverty of speech. There is relatively good consistency across these studies, which come from both the United States and Europe and used 4 different instruments. The SDS-based study of Kimhy et al.11—which included only those patients judged to have primary negative symptoms—as well as the study of Kirkpatrick et al.15—which included patients with and without primary negative symptoms—both supported the existence of a particularly strong relationship between blunted affect and poverty of speech. The other studies were based on instruments that are not intended to distinguish primary versus secondary symptoms, providing further support for the generalizability of the conclusion.


   Future Research
Top
 Blunted Affect
 Data at the Item...
 Future Research
Conclusion
 References
 
Taken together, the studies cited above and the review of Blanchard and Cohen1 suggest that blunted affect has a particularly strong relationship to poverty of speech, with these 2 features forming an "expressivity" domain within negative symptoms. The reported independence of social skills and subjective experience from blunted affect16,17 is also consistent with the existence of multiple factors within negative symptoms.

Flat or blunted affect alone has sometimes been used as an independent variable in studies of course, psychopathology, and neurobiology, and in some contexts it has been a significant predictor of other variables.18–22 However, in most studies the potential for confounding by other negative symptoms has not been considered, so the specificity of the relationships with blunted affect is not clear. The study of Gur et al.23 in this issue is a notable exception. We are not aware of any published studies that have considered the correlates of an expressivity factor and an anhedonia/asociality factor separately, although at the Consensus Development Conference, Malaspina presented data suggesting that these factors do have different correlates.

It would not be difficult to test the hypothesis that these factors have different correlates by conducting secondary analyses. In many studies for which negative symptoms are an important dependent variable, expressivity and anhedonia/asociality factor scores can be derived from the Scale for Assessment of Negative Symptoms (SANS) and some other negative symptom rating scales. For instance, blunted affect is very similar to the neurological concept of aprosodia; thus, the anatomical organization of aprosodia provides a conceptual framework for developing hypotheses about the putative expressivity component of negative symptoms.24–30 In most subjects, prosody appears to be under the control of areas in the right hemisphere, with an organization that mirrors that of propositional language in the left, such that separate areas control emotional (versus propositional) expression and comprehension. That is, both expressive and receptive aprosodias exist, with a right-sided anatomical organization that mirrors that of expressive and receptive aphasias in the left hemisphere.

Propositional and affective components of language are thought to be integrated in the brainstem and via the corpus callosum. A smaller volume of the corpus callosum was associated with negative symptoms in two studies,31,32 although not in a third.33 Is the volume of the corpus callosum related to the severity of expressivity factor but not to an anhedonia/asociality/avolition factor?

More generally, are other variables related to negative symptoms linked exclusively or primarily to 1 of the 2 factors described by Blanchard and Cohen?1 What about cognitive function or regional brain activation in schizophrenia, or subclinical negative symptoms in the relatives of probands with schizophrenia?


   Conclusion
Top
 Blunted Affect
 Data at the Item...
 Future Research
 Conclusion
References
 
The psychometric association of blunted affect and poverty of speech raises the possibility that an expressivity factor has an independence from other negative symptoms that extends to course of illness, treatment response, and neurobiology. In analyses of negative symptoms, an additional analysis of an expressivity factor versus other negative symptoms would add little additional work but may improve our understanding of negative symptoms and schizophrenia.


  Footnotes
 
1To whom correspondence should be addressed; e-mail: bkirkpatrick2{at}aol.com.


   References
Top
 Blunted Affect
 Data at the Item...
 Future Research
 Conclusion
 References
 

  1. Blanchard, JJ and Cohen, AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2006; 32:2 First published on October 27, 2005, doi:10.1093/schbul/sbj013.

  2. Constantino, JN, Gruber, CP, Davis, S, Hayes, S, Passanante, N, Przybeck, T. The factor structure of autistic traits. J Child Psychol Psychiatry 2004; 45:719–726.[CrossRef][Web of Science][Medline]

  3. Fetoni, V, Soliveri, P, Monza, D, Testa, D, Girotti, F. Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 1999; 66:541–544.[Abstract/Free Full Text]

  4. Tremeau, F, Malaspina, D, Duval, F, et al. Facial expressiveness in patients with schizophrenia compared to depressed patients and nonpatient comparison subjects. Am J Psychiatry 2005; 162:92–101.[Abstract/Free Full Text]

  5. Jouvent, R, Le Houezec, J, Payan, C, et al. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation. Psychiatry Res 1998; 79:3267–275.[CrossRef][Web of Science][Medline]

  6. Robertson, JM, Tanguay, PE, L'ecuyer, S, Sims, A, Waltrip, C. Domains of social communication handicap in autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:738–745.[CrossRef][Web of Science][Medline]

  7. Sultzer, DL, Levin, HS, Mahler, ME, High, WM, Cummings, JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 1993; 150:1806–1812.[Abstract/Free Full Text]

  8. Van Putten, T and May, RP. "Akinetic depression" in schizophrenia. Arch Gen Psychiatry 1978; 35:1101–1107.[Abstract/Free Full Text]

  9. Alphs, LD, Summerfelt, A, Lann, H, Muller, R. The Negative Symptom Assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacol Bull 1989; 25:159–163.[Web of Science][Medline]

  10. Keefe, RSE, Harvey, PD, Lenzenweger, MF, et al. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res 1992; 44:153–165.[CrossRef][Medline]

  11. Kimhy, D, Yale, S, Goetz, RR, McFarr, LM, Malaspina, D. The Factorial Structure of the Scale for Deficit Syndrome in schizophrenia. Schizophr Bull 2006; 32:2 First published on September 21, 2005, doi:10.1093/schbul/sbi064.

  12. Peralta, V and Cuesta, MJ. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. Am J Psychiatry 1995; 152:1450–1457.[Abstract/Free Full Text]

  13. Axelrod, BN, Goldman, RS, Woodard, JL, Alphs, LD. Factor structure of the Negative Symptom Assessment. Psychiatry Res 1994; 52:173–179.[CrossRef][Web of Science][Medline]

  14. de Leon, J, Peralta, V, Cuesta, MJ. Negative symptoms and emotional blunting in schizophrenic patients. J Clin Psychiatry 1993; 54:3103–108.[Medline]

  15. Kirkpatrick, B, Buchanan, RW, McKenny, PD, Alphs, LD, Carpenter, WT Jr. The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989; 30:119–123.[CrossRef][Web of Science][Medline]

  16. Salem, JE and Kring, AM. Flat affect and social skills in schizophrenia: evidence for their independence. Psychiatry Res 1999; 87:159–167.[CrossRef][Web of Science][Medline]

  17. Myin-Germeys, I, Delespaul, PAEG, deVries, MW. Schizophrenia patients are more emotionally active than is assumed based on their behavior. Schizophr Bull 2000; 26:847–854.[Abstract/Free Full Text]

  18. Carpenter, WT Jr and Strauss, JS. The prediction of outcome in schizophrenia. IV. eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991; 179:517–525.[Web of Science][Medline]

  19. Eaton, WW, Thara, R, Federman, E, Tien, A. Remission and relapse in schizophrenia: the Madras Longitudinal Study. J Nerv Ment Dis 1998; 186:6357–363.[CrossRef][Web of Science][Medline]

  20. Suslow, T, Roestel, C, Ohrman, P, Arolt, V. Detection of facial expressions of emotions in schizophrenia. Schizophr Res 2003; 64:137–145.[Web of Science][Medline]

  21. Thara, R and Eaton, WW. Outcome of schizophrenia: the Madras Longitudinal Study. Aust N Z J Psychiatry 1996; 30:516–522.[Web of Science][Medline]

  22. Yamasue, H, Fukui, T, Fukuda, R, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 2002; 13:2133–2137.[CrossRef][Web of Science][Medline]

  23. Gur, R, Kohler, C, Ragland, J, et al. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr Bull 2006; 32:2 First published on February 1, 2005, doi:10.1093/schbul/sbj041.

  24. Gorelick, PB and Ross, ED. The aprosodias: further functional-anatomical evidence for the organisation of affective language in the right hemisphere. J Neurol Neurosurg Psychiatry 1987; 50:553–560.[Abstract/Free Full Text]

  25. Ross, ED. The aprosodias: functional-anatomic organization of the affective components of language in the right hemisphere. Arch Neurol 1981; 38:561–569.[Abstract/Free Full Text]

  26. Ross, ED, Anderson, B, Morgan-Fisher, A. Crossed aprosodia in strongly dextral patients. Arch Neurol 1989; 46:206–209.[Abstract/Free Full Text]

  27. Ross, ED, Harney, JH, deLacoste-Utamsing, C, Purdy, PD. How the brain integrates affective and propositional language into a unified behavioral function: hypothesis based on clinicoanatomic evidence. Arch Neurol 1981; 38:745–748.[Abstract/Free Full Text]

  28. Ross, ED, Orbelo, DM, Cartwright, J, et al. Affective-prosodic deficits in schizophrenia: comparison to patients with brain damage and relation to schizophrenic symptoms. J Neurol Neurosurg Psychiatry 2001; 70:597–604.[Abstract/Free Full Text]

  29. Wolfe, GI and Ross, ED. Sensory aprosodia with left hemiparesis from subcortical infarction: right hemisphere analogue of sensory-type aphasia with right hemiparesis? Arch Neurol 1987; 44:668–671.[Abstract/Free Full Text]

  30. Wymer, JH, Lindman, LS, Booksh, RL. A neuropsychological perspective of aprosody: features, function, assessment, and treatment. Appl Neuropsychol 2002; 9:37–47.[CrossRef][Medline]

  31. Tibbo, P, Nopoulos, P, Arndt, S, Andreasen, NC. Corpus callosum shape and size in male patients with schizophrenia. Biol Psychiatry 1998; 44:405–412.[CrossRef][Web of Science][Medline]

  32. Gunther, W, Petsch, R, Steinberg, R, et al. Brain dysfunction during motor activation and corpus callosum alterations in schizophrenia measured by cerebral blood flow and magnetic resonance imaging. Biol Psychiatry 1991; 29:535–555.[CrossRef][Web of Science][Medline]

  33. Mathew, RJ, Partain, CL, Prakash, R, Kulkarni, MV, Logan, TP, Wilson, WH. A study of the septum pellucidum and corpus callosum in schizophrenia with MR imaging. Acta Psychiatr Scand 1985; 72:414–421.[Web of Science][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
32/2/246    most recent
sbj054v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kirkpatrick, B.
Right arrow Articles by Fischer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirkpatrick, B.
Right arrow Articles by Fischer, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?